Nature Reviews Gastroenterology & Hepatology
Scope & Guideline
Transforming Research into Clinical Practice
Introduction
Aims and Scopes
- Microbiome and Gut Health:
The journal emphasizes the role of the gut microbiome in gastrointestinal health and disease, exploring its interactions with host physiology, immune responses, and its implications for conditions such as inflammatory bowel disease (IBD), liver diseases, and metabolic disorders. - Liver Diseases and Management:
A significant focus is placed on various liver diseases, including hepatitis, nonalcoholic fatty liver disease (NAFLD), and hepatocellular carcinoma (HCC). The journal discusses emerging therapies, clinical trial outcomes, and the pathophysiological mechanisms underlying these conditions. - Innovative Therapeutics and Clinical Trials:
Nature Reviews Gastroenterology & Hepatology highlights innovative therapeutic strategies, including the use of biologics, small molecules, and regenerative medicine approaches, along with detailed discussions on the design and outcomes of clinical trials. - Immunology and Inflammation:
The journal explores the immunological aspects of gastrointestinal and liver diseases, focusing on the roles of immune cells, inflammatory pathways, and the impact of immunotherapy on treatment outcomes. - Translational Research and Precision Medicine:
There is a strong emphasis on the translation of basic research findings into clinical practice, with a focus on precision medicine approaches that tailor treatments to individual patient characteristics and disease mechanisms. - Public Health and Epidemiology:
The journal also addresses the public health implications of gastrointestinal and liver diseases, including epidemiological trends, prevention strategies, and health disparities.
Trending and Emerging
- Artificial Intelligence and Machine Learning:
There is a notable increase in the exploration of artificial intelligence (AI) and machine learning applications in gastroenterology, particularly in diagnostic imaging, predictive analytics, and personalized treatment plans. - Microbiome Research and Therapeutics:
Research focusing on the gut microbiome as a therapeutic target is rapidly expanding, with increasing interest in microbiome modulation for managing gastrointestinal and liver diseases. - Patient-Centered Care and Health Equity:
Emerging themes around patient-centered care and health equity are gaining traction, emphasizing the importance of addressing social determinants of health and ensuring equitable access to care. - Immunotherapy and Novel Therapeutics:
The trend towards immunotherapy and other novel therapeutic approaches for treating liver cancer and IBD is growing, reflecting advancements in understanding disease mechanisms and treatment outcomes. - Environmental and Lifestyle Factors:
There is a rising focus on the impact of environmental and lifestyle factors on gastrointestinal health, including the effects of diet, pollution, and socio-economic status on disease risk and management. - Digital Health and Telemedicine:
The integration of digital health technologies, including telemedicine, into clinical practice is an emerging area of interest, particularly in the context of managing chronic gastrointestinal conditions.
Declining or Waning
- Traditional Dietary Approaches:
There appears to be a waning interest in traditional dietary management strategies for gastrointestinal diseases, as newer therapeutic interventions and precision medicine approaches gain prominence in research and clinical practice. - Conventional Imaging Techniques:
The emphasis on conventional imaging techniques for diagnosing gastrointestinal and liver diseases is decreasing, with a growing focus on advanced imaging modalities and biomarkers that offer more precise and detailed insights. - Generalized Liver Disease Management:
The discussion around generalized management strategies for liver diseases is declining, as more nuanced and specific treatment protocols tailored to individual patient needs and disease subtypes are being developed. - Basic Science without Clinical Relevance:
There is less emphasis on purely basic science studies that do not have immediate clinical relevance, as the journal increasingly prioritizes research that bridges the gap between basic science and clinical application.
Similar Journals
Gastroenterology Review-Przeglad Gastroenterologiczny
Advancing Gastrointestinal Knowledge for a Healthier TomorrowGastroenterology Review-Przeglad Gastroenterologiczny is a premier, peer-reviewed journal published by TERMEDIA PUBLISHING HOUSE LTD, focusing on the dynamic field of gastroenterology. Since its inception in 2006, it has embraced an Open Access model, ensuring that the latest research is readily accessible to a global audience, fostering collaboration and innovation. Based in Poland, this journal serves as a crucial platform for disseminating significant findings in gastrointestinal research, with a current Scopus rank placing it at the 39th percentile in its category. With a commitment to advancing the understanding of gastroenterological conditions, *Gastroenterology Review* publishes original articles, reviews, and case studies that contribute to both clinical practice and academic research. The journal is particularly aimed at researchers, healthcare professionals, and students who ignite dialogues that shape the future of gastrointestinal health. Explore the comprehensive insights that this journal offers, as it encapsulates vital developments from 2008 to 2024 in the ever-evolving landscape of gastroenterology.
Gastroenterology
Elevating Knowledge in Gastroenterology and HepatologyGastroenterology, published by W B Saunders Co-Elsevier Inc, is a premier journal dedicated to advancing the knowledge and practice within the fields of gastroenterology and hepatology. Established in 1945 and covering a wide range of topics related to digestive health, this journal holds a distinguished position in the academic community, as evidenced by its impressive Q1 status in both Gastroenterology and Hepatology categories, and its high rankings (4th in both disciplines) in Scopus, placing it in the top percentile for scholarly impact. With its commitment to publishing high-quality research, reviews, and clinical studies, Gastroenterology provides an essential resource for researchers, healthcare professionals, and students seeking cutting-edge insights that inform clinical practices and enhance patient care. Although it does not currently offer open access, the journal continues to serve as a vital platform for disseminating meaningful research that shapes the future of digestive disease management.
Journal of Clinical and Experimental Hepatology
Exploring the frontiers of hepatology for a healthier tomorrow.The Journal of Clinical and Experimental Hepatology, published by Elsevier - Division Reed Elsevier India Pvt Ltd, is a premier platform dedicated to advancing the field of hepatology. With an ISSN of 0973-6883 and an E-ISSN of 2213-3453, this journal has gained recognition for its impactful contributions to both clinical practice and scientific research in the domain of liver health. Ranking in the Q2 quartile for Hepatology in 2023 and positioned at 33rd out of 82 in Scopus’s Hepatology category, it reflects a robust impact factor and a commitment to publishing high-quality, peer-reviewed articles. Researchers, clinicians, and students can engage with a wealth of open-access content covering the latest advancements, challenges, and insights in hepatology, as the journal aims to disseminate knowledge from 2011 through 2025. Join the community of experts as we explore critical developments in the understanding and treatment of liver diseases.
JGH Open
Transforming Discovery into Practice in GastroenterologyJGH Open is a prominent open-access journal dedicated to advancing knowledge in the fields of Gastroenterology and Hepatology, published by WILEY. Since its inception in 2017, the journal has served as a crucial platform for researchers, professionals, and students to disseminate innovative research findings and clinical insights. With an impact factor and Scopus rankings reflecting its steady growth—ranking in the 3rd quartile for both Gastroenterology (Q3) and Hepatology (Q3)—JGH Open is positioned within the competitive landscape of medicine. Its commitment to open access enhances the visibility and accessibility of high-quality research, ensuring that significant advancements in understanding diseases of the gastrointestinal tract and liver reach a broad audience. With a focus on collaboration and dissemination of knowledge, JGH Open aims to contribute to the global discourse and improve outcomes in gastrointestinal health.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
Advancing pediatric health through nutrition and gastrointestinal research.Journal of Pediatric Gastroenterology and Nutrition is a premier academic journal published by Wiley, focusing on the critical intersection of pediatric gastroenterology and nutrition. Established in 1982, this journal has been at the forefront of research and clinical practices for over four decades and continues to contribute invaluable insights to the fields of pediatrics and gastrointestinal health, boasting a Q1 ranking in Pediatrics, Perinatology and Child Health and a Q2 ranking in Gastroenterology as of 2023. The journal features a comprehensive array of original research, review articles, and clinical studies aimed at improving the understanding and management of pediatric gastrointestinal disorders and nutrient imbalances. Edited with expertise, the Journal of Pediatric Gastroenterology and Nutrition serves as an essential resource for clinicians, researchers, and students dedicated to advancing the well-being of children with digestive health issues. Readers can access the journal's impactful research studies through traditional subscriptions.
DIGESTIVE DISEASES
Uncovering Breakthroughs in Gastroenterology.DIGESTIVE DISEASES, published by KARGER, stands as a leading international journal dedicated to the field of gastroenterology and digestive health. With an ISSN of 0257-2753 and E-ISSN 1421-9875, the journal has been providing a platform for high-quality research since its inception in 1983, continuing to disseminate groundbreaking findings and insights through to 2024. Positioned in the second quartile (Q2) of both the gastroenterology and miscellaneous medicine categories as of 2023, DIGESTIVE DISEASES is recognized for its rigorous peer-review process and its contributions to advancing clinical and experimental gastroenterological knowledge. Its Scopus ranking at #62 out of 167 in the gastroenterology field reflects its significant impact, as it reaches a notable 63rd percentile among its peers. While it does not currently offer open access options, its subscription model ensures that vital research is available to professionals and institutions committed to the field. The journal serves as an essential resource for researchers, clinicians, and students alike who seek to deepen their understanding of digestive disorders and their implications in medicine.
Clinical Gastroenterology and Hepatology
Bridging Science and Practice in Digestive HealthClinical Gastroenterology and Hepatology, published by Elsevier Science Inc, stands as a leading journal in the fields of gastroenterology and hepatology. With an ISSN of 1542-3565 and an E-ISSN of 1542-7714, this esteemed publication has earned its place in the top quartile (Q1) of both gastroenterology and hepatology categories as of 2023, ranking 6th out of 167 and 7th out of 82 respectively. The journal aims to disseminate innovative research, clinical studies, and case reports that advance the understanding and treatment of gastrointestinal and liver diseases. Targeted towards researchers, healthcare professionals, and students, it provides crucial insights into emerging therapies and medical advancements. Clinical Gastroenterology and Hepatology is not only a pivotal resource for contemporary gastroenterological research but also fosters collaboration and knowledge-sharing within the medical community. With a converging publication history from 2003 to the present, the journal continues to build on its solid foundation of scientific excellence and relevance.
Cellular and Molecular Gastroenterology and Hepatology
Advancing knowledge in gastrointestinal and liver health.Cellular and Molecular Gastroenterology and Hepatology, published by Elsevier Inc, is a premier Open Access journal dedicated to advancing the understanding and treatment of gastrointestinal and liver diseases. Since its inception in 2015, this journal has established itself as a leading publication within its field, boasting impressive metrics with a 2023 Q1 ranking in both Gastroenterology and Hepatology. It ranks #10 out of 167 in Gastroenterology and #11 out of 82 in Hepatology on Scopus, placing it in the 94th and 87th percentiles, respectively. This journal aims to disseminate high-quality, peer-reviewed research that fosters innovative solutions for clinical challenges, making it an invaluable resource for researchers, healthcare professionals, and students alike. With open access, all published content is readily available to a global audience, ensuring that critical findings in cellular and molecular biology related to gastroenterology and hepatology reach those who can benefit the most from the latest advances in the field. For more information, please visit us at our address in San Diego, CA, or explore our articles online.
Gastroenterologia y Hepatologia
Advancing knowledge in gastrointestinal and liver health.Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Transforming insights into clinical practices.The EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, serves as a key platform for disseminating cutting-edge research in the fields of gastroenterology and hepatology since its inception in 1989. With its ISSN 0954-691X and E-ISSN 1473-5687, the journal has established a prominent reputation, as reflected in its 2023 rankings, placing it in Q2 for Gastroenterology and Q3 for Hepatology. It is ranked #75 out of 167 in gastroenterology and #39 out of 82 in hepatology according to Scopus, highlighting its importance in advancing knowledge and clinical practices. While it does not currently offer open access options, the journal remains essential for researchers, healthcare professionals, and students seeking to stay abreast of significant developments and innovations in digestive health. By providing rigorous peer-reviewed articles, the EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY continues to contribute to the understanding and treatment of gastrointestinal and liver diseases, making it a vital resource in the medical community.